Risk factors for the perineal incision complications after abdominoperineal excision for rectal cancer

王超,王畅,高志冬,梁斌,杨晓东,尹慕军,姜可伟,谢启伟
DOI: https://doi.org/10.3760/cma.j.issn.1671-0274.2016.04.010
2016-01-01
Abstract:Objective To evaluate the factors affecting perineal incision complications after abdominperineal excision (APE) for rectal cancer. Methods This was a retrospective study of 167 patients with rectal cancer undergoing APE at Peking University People′s Hospital between October 1998 and December 2013. Chi-square test and multivariate Logistic regression analysis were used to identify risk factors. Results The overall rate of perineal incision complication was 24.6%(41/167) including 7 cases of incision infection, 10 cases of incision fat liquefaction, 21 cases of poor wound healing, 2 cases of incision fistula, 1 case of incision dehiscence. In univariate analysis, the risk factors associated with perineal incision complication were operating time≥280 minutes (P = 0.005), blood loss≥350 ml (P = 0.017) and the protective factors associated with perineal incision complication were the procedure of APE (P = 0.048), intraperitoneal chemotherapy with 5-FU sustained release (P=0.014), lymph node metastasis (P=0.006), while gender, age, BMI, ASA score, other complications, distance from distal tumor to anal verge, preoperative radiochemotherapy, postoperative stay in ICU, total drainage volume 3 days before operation, tumor differentiation, and postoperative TNM staging were not associated with perineal incision complication (all P>0.05). Multivariate logistic regression analysis identified two independent risk factors:operating time ≥ 280 minutes (OR = 5.217, 95% CI:1.250 - 6.234, P = 0.000), intraperitoneal chemotherapy with 5-FU sustained release (OR= 3.284, 95% CI:1.156 - 9.334, P = 0.026). Conclusions Operating time≥280 minutes and intraperitoneal chemotherapy with 5-FU sustained release are independent risk factors for perineal incision complications after APE for rectal cancer. For patients receiving APE procedure, intraperitoneal chemotherapy with 5-FU sustained release should be used with caution, and the operative time should be reduced when possible.
What problem does this paper attempt to address?